4-acylaminopyridine derivative mediated neurogenesis

Details for Australian Patent Application No. 2007212349 (hide)

Owner Mitsubishi Tanabe Pharma Corporation

Inventors Barlow, Carrolee

Agent Griffith Hack

Pub. Number AU-A-2007212349

PCT Pub. Number WO2007/092535

Priority 60/771,090 07.02.06 US

Filing date 6 February 2007

Wipo publication date 16 August 2007

International Classifications

A61K 31/44 (2006.01) - Non-condensed pyridines

A61K 31/4741 (2006.01)

C07D 491/02 (2006.01) Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or

Event Publications

4 September 2008 PCT application entered the National Phase

  PCT publication WO2007/092535 Priority application(s): WO2007/092535

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007212381-Management of high-availability power infrastructures

2007212345-Compounds and compositions as protein kinase inhibitors